MedTrace Logo

Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects

NCT03013842 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-01-31

No results posted yet for this study

Summary

Three non-invasive, trans-abdominal fetal oximetry probes will be tested on pregnant human subjects, in order to obtain fetal heart rate.

We want to determine if this device can accurately measure a baby's oxygen level when placed on your abdomen.

Current technology to measure a baby's oxygen levels requires a probe to be inserted into the vagina.

Conditions

  • Pregnancy, Abdominal

Interventions

DEVICE

Raydiant Oximetry Sensor System

Administration of Fetal Oximetry Probe on 36 weeks or greater pregnant women

Sponsors & Collaborators

  • CITRIS

    collaborator UNKNOWN

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Neil Ray, MD · 916-734-5028

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-12
Primary Completion
2017-08-02
Completion
2017-08-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03013842 on ClinicalTrials.gov